2018
DOI: 10.1002/adtp.201800066
|View full text |Cite
|
Sign up to set email alerts
|

Energy‐Coupling Factor Transporters as Novel Antimicrobial Targets

Abstract: In an attempt to find new antibiotics, novel ways of interfering with important biological functions should be explored, especially with those which are necessary or even irreplaceable for bacterial survival, growth, and virulence. The purpose of this review is to highlight B-type vitamin transporters from the energy-coupling factor (ECF) family, which are not present in humans, as potential antimicrobial targets. In addition, a druggability analysis of an ECF transporter for folic acid and sequence-conservati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
42
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 26 publications
(42 citation statements)
references
References 108 publications
0
42
0
Order By: Relevance
“…However, analysis revealed with high confidence the transporter gene cytX in all R. inulinivorans genomes that carries hydroxymethylpyrimidine [ 114 ], which can then be converted into a precursor for thiamine with the bifunctional enzyme thiD . Additionally, we found evidence for a thiamine energy coupling factor (ECF) transporter [ 115 ], thiT , in all species except R. faecis .…”
Section: Resultsmentioning
confidence: 99%
“…However, analysis revealed with high confidence the transporter gene cytX in all R. inulinivorans genomes that carries hydroxymethylpyrimidine [ 114 ], which can then be converted into a precursor for thiamine with the bifunctional enzyme thiD . Additionally, we found evidence for a thiamine energy coupling factor (ECF) transporter [ 115 ], thiT , in all species except R. faecis .…”
Section: Resultsmentioning
confidence: 99%
“…ECF transporter complexes have recently gained renewed attention with the identification of a novel haem transporter belonging to the family of ECF-type ABC transporters (34)(35)(36). As various ECF transporters complexes are encoded in the genome of various human pathogens but not in humans (37,38), it makes them attractive targets for newly designed antimicrobial compounds, for which this work represents a stepping stone towards studying their means of action on a structural level.…”
Section: Discussionmentioning
confidence: 99%
“…Transporters from the ECF family, which are not present in humans, have been proposed as potential antimicrobial targets. Assessment of the likelihood to find a selective, low-molecular weight molecule that binds with high affinity to the target, which is usually referred to as druggability assessment, identified up to twelve druggable pockets within a reference ECF transporter system [63]. An alternative approach to prevent metal acquisition could be either the inhibition of binding of the S-components to the ECF module or the inhibition of their ability to bind metals.…”
Section: Discussionmentioning
confidence: 99%